Inspire Medical Systems
INSP
301 hedge funds and large institutions have $5.01B invested in Inspire Medical Systems in 2022 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 119 increasing their positions, 97 reducing their positions, and 25 closing their positions.
194% more call options, than puts
Call options by funds: $120M | Put options by funds: $40.8M
68% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 25
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
23% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 97
5% more funds holding
Funds holding: 286 → 301 (+15)
0% more capital invested
Capital invested by funds: $5.01B → $5.01B (+$1.28M)
0.77% less ownership
Funds ownership: 99.43% → 98.66% (-0.77%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$48M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$39.2M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$32.6M |
| 4 |
Goldman Sachs
New York
|
+$29.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$146M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$26.6M |
| 3 |
FAM
Fred Alger Management
New York
|
-$26.3M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$23.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$18.3M |
INSP Hedge Fund Activity: Q3 2022 in Review
301 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q3 2022, worth a combined $5.01B — up 0.03% from $5.01B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new INSP positions and 25 closed out — a net gain of 17 holders — while 119 added to existing stakes and 97 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $48M. The largest seller was Fidelity Investments, cutting an estimated $146M.
- 301 institutional investors held Inspire Medical Systems (INSP) as of Q3 2022, up from 286 in Q2 2022.
- Funds reported $5.01B of Inspire Medical Systems stock for Q3 2022, up 0.03% quarter-over-quarter.
- 42 funds opened new Inspire Medical Systems positions in Q3 2022 and 25 closed out, a net change of +17 holders.
- The largest Inspire Medical Systems buyer in Q3 2022 was Citadel Advisors, an estimated $48M added.
- The largest Inspire Medical Systems seller in Q3 2022 was Fidelity Investments, an estimated $146M sold.
Based on aggregated 13F filings for Q3 2022.